IKK alpha Antibody - #DF6792
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF6792, RRID:AB_2838754.
折りたたみ/展開
chuk; CHUK1; Conserved Helix Loop Helix Ubiquitous Kinase; Conserved helix loop ubiquitous kinase; Conserved helix-loop-helix ubiquitous kinase; I Kappa B Kinase 1; I Kappa B Kinase Alpha; I-kappa-B kinase 1; I-kappa-B kinase alpha; IkappaB kinase; IkB kinase alpha subunit; IkBKA; IKK 1; IKK A; IKK a kinase; IKK-A; IKK-alpha; IKK1; IKKA; IKKA_HUMAN; Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B Cells; Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit; Inhibitor of nuclear factor kappa-B kinase subunit alpha; NFKBIKA; Nuclear Factor Kappa B Inhibitor Kinase Alpha; Nuclear factor NF kappa B inhibitor kinase alpha; Nuclear factor NF-kappa-B inhibitor kinase alpha; Nuclear factor NFkappaB inhibitor kinase alpha; Nuclear Factor Of Kappa Light Chain Gene Enhancer In B Cells Inhibitor; TCF-16; TCF16; Transcription factor 16;
免疫原
- O15111 IKKA_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGSLCTSFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLVVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQSSARSLVGSSLEGAVTPQTSAWLPPTSAEHDHSLSCVVTPQDGETSAQMIEENLNCLGHLSTIIHEANEEQGNSMMNLDWSWLTE
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O15111 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
T23 | Phosphorylation | Q9Y243 (AKT3) , O00141 (SGK1) , P31749 (AKT1) , P31751 (AKT2) | Uniprot |
K44 | Ubiquitination | Uniprot | |
K53 | Ubiquitination | Uniprot | |
K67 | Ubiquitination | Uniprot | |
K105 | Ubiquitination | Uniprot | |
K109 | Ubiquitination | Uniprot | |
K117 | Ubiquitination | Uniprot | |
S119 | Acetylation | Uniprot | |
K139 | Ubiquitination | Uniprot | |
K146 | Ubiquitination | Uniprot | |
K158 | Ubiquitination | Uniprot | |
Y168 | Phosphorylation | Uniprot | |
S176 | Phosphorylation | Q04759 (PRKCQ) , Q99558 (MAP3K14) | Uniprot |
T179 | Acetylation | Uniprot | |
S180 | Phosphorylation | Q04759 (PRKCQ) , Q99558 (MAP3K14) | Uniprot |
K296 | Ubiquitination | Uniprot | |
K322 | Acetylation | Uniprot | |
K366 | Ubiquitination | Uniprot | |
K391 | Ubiquitination | Uniprot | |
K415 | Ubiquitination | Uniprot | |
K438 | Acetylation | Uniprot | |
T463 | Phosphorylation | Uniprot | |
S473 | Phosphorylation | Q13315 (ATM) | Uniprot |
Y500 | Phosphorylation | Uniprot | |
K506 | Ubiquitination | Uniprot | |
S536 | Phosphorylation | Uniprot | |
K569 | Ubiquitination | Uniprot | |
K572 | Ubiquitination | Uniprot | |
S576 | Phosphorylation | Uniprot | |
T593 | Phosphorylation | Uniprot | |
K602 | Ubiquitination | Uniprot | |
K615 | Ubiquitination | Uniprot | |
K617 | Ubiquitination | Uniprot | |
K624 | Ubiquitination | Uniprot | |
T722 | Acetylation | Uniprot |
PTMs - O15111 酵素として
Substrate | Site | Source |
---|---|---|
O14920-1 (IKBKB) | S177 | Uniprot |
O14920-1 (IKBKB) | S181 | Uniprot |
O43524 (FOXO3) | S644 | Uniprot |
O75925-1 (PIAS1) | S90 | Uniprot |
P03372 (ESR1) | S118 | Uniprot |
P19838-2 (NFKB1) | S922 | Uniprot |
P19838 (NFKB1) | S923 | Uniprot |
P19838-2 (NFKB1) | S924 | Uniprot |
P19838 (NFKB1) | S927 | Uniprot |
P19838-2 (NFKB1) | S928 | Uniprot |
P19838 (NFKB1) | T931 | Uniprot |
P19838 (NFKB1) | S932 | Uniprot |
P19838-2 (NFKB1) | T932 | Uniprot |
P19838-2 (NFKB1) | S933 | Uniprot |
P24385 (CCND1) | T286 | Uniprot |
P25963 (NFKBIA) | S32 | Uniprot |
P25963 (NFKBIA) | S36 | Uniprot |
P35222 (CTNNB1) | S33 | Uniprot |
P35222 (CTNNB1) | S37 | Uniprot |
P35222 (CTNNB1) | T41 | Uniprot |
P35222 (CTNNB1) | S45 | Uniprot |
P42345 (MTOR) | S1415 | Uniprot |
P84243 (H3F3B) | S11 | Uniprot |
Q00653 (NFKB2) | S99 | Uniprot |
Q00653 (NFKB2) | S108 | Uniprot |
Q00653 (NFKB2) | S115 | Uniprot |
Q00653 (NFKB2) | S123 | Uniprot |
Q00653 (NFKB2) | S872 | Uniprot |
Q01094 (E2F1) | S403 | Uniprot |
Q01201 (RELB) | S472 | Uniprot |
Q04206 (RELA) | S536 | Uniprot |
Q04864 (REL) | S557 | Uniprot |
Q14164 (IKBKE) | S172 | Uniprot |
Q15653-1 (NFKBIB) | S19 | Uniprot |
Q15653-1 (NFKBIB) | S23 | Uniprot |
Q15717 (ELAVL1) | S304 | Uniprot |
Q5S007 (LRRK2) | S910 | Uniprot |
Q5S007 (LRRK2) | S935 | Uniprot |
Q86VP1-2 (TAX1BP1) | S593 | Uniprot |
Q86VP1-2 (TAX1BP1) | S624 | Uniprot |
Q86VP1 (TAX1BP1) | S666 | Uniprot |
Q92793 (CREBBP) | S1382 | Uniprot |
Q92793 (CREBBP) | S1386 | Uniprot |
Q99558 (MAP3K14) | T559 | Uniprot |
Q9BUZ4 (TRAF4) | S426 | Uniprot |
Q9BXH1 (BBC3) | S10 | Uniprot |
Q9NQC7 (CYLD) | S418 | Uniprot |
Q9NQC7 (CYLD) | S422 | Uniprot |
Q9NQC7 (CYLD) | S432 | Uniprot |
Q9NQC7 (CYLD) | S436 | Uniprot |
Q9NQC7 (CYLD) | S439 | Uniprot |
Q9NQC7 (CYLD) | S441 | Uniprot |
Q9NQC7 (CYLD) | S444 | Uniprot |
Q9Y261 (FOXA2) | S107 | Uniprot |
Q9Y261 (FOXA2) | S111 | Uniprot |
Q9Y6Q9-5 (NCOA3) | S857 | Uniprot |
研究背景
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor. Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity).
Phosphorylated by MAP3K14/NIK, AKT and to a lesser extent by MEKK1, and dephosphorylated by PP2A. Autophosphorylated.
(Microbial infection) Acetylation of Thr-179 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the I-kappa-B signaling pathway.
Cytoplasm. Nucleus.
Note: Shuttles between the cytoplasm and the nucleus.
Widely expressed.
Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65 (By similarity). Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Part of a 70-90 kDa complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14. Directly interacts with TRPC4AP (By similarity). May interact with TRAF2. Interacts with NALP2. May interact with MAVS/IPS1. Interacts with ARRB1 and ARRB2. Interacts with NLRC5; prevents CHUK phosphorylation and kinase activity. Interacts with PIAS1; this interaction induces PIAS1 phosphorylation. Interacts with ZNF268 isoform 2; the interaction is further increased in a TNF-alpha-dependent manner. Interacts with FOXO3. Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation. Interacts with LRRC14. Interacts with SASH1.
(Microbial infection) Interacts with InlC of Listeria monocytogenes.
The kinase domain is located in the N-terminal region. The leucine zipper is important to allow homo- and hetero-dimerization. At the C-terminal region is located the region responsible for the interaction with NEMO/IKBKG.
Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.
研究領域
· Cellular Processes > Cell growth and death > Apoptosis. (View pathway)
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > FoxO signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > mTOR signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > TNF signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > Antifolate resistance.
· Human Diseases > Infectious diseases: Bacterial > Epithelial cell signaling in Helicobacter pylori infection.
· Human Diseases > Infectious diseases: Bacterial > Shigellosis.
· Human Diseases > Infectious diseases: Parasitic > Chagas disease (American trypanosomiasis).
· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.
· Human Diseases > Infectious diseases: Viral > Hepatitis C.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Infectious diseases: Viral > Measles.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Infectious diseases: Viral > HTLV-I infection.
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Pancreatic cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Prostate cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia. (View pathway)
· Human Diseases > Cancers: Specific types > Acute myeloid leukemia. (View pathway)
· Human Diseases > Cancers: Specific types > Small cell lung cancer. (View pathway)
· Organismal Systems > Immune system > Chemokine signaling pathway. (View pathway)
· Organismal Systems > Development > Osteoclast differentiation. (View pathway)
· Organismal Systems > Immune system > Toll-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > NOD-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway. (View pathway)
· Organismal Systems > Immune system > IL-17 signaling pathway. (View pathway)
· Organismal Systems > Immune system > Th1 and Th2 cell differentiation. (View pathway)
· Organismal Systems > Immune system > Th17 cell differentiation. (View pathway)
· Organismal Systems > Immune system > T cell receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > B cell receptor signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Adipocytokine signaling pathway.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.